Literature DB >> 26912861

mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle.

Issam Ben-Sahra1, Gerta Hoxhaj1, Stéphane J H Ricoult1, John M Asara2, Brendan D Manning1.   

Abstract

In response to growth signals, mechanistic target of rapamycin complex 1 (mTORC1) stimulates anabolic processes underlying cell growth. We found that mTORC1 increases metabolic flux through the de novo purine synthesis pathway in various mouse and human cells, thereby influencing the nucleotide pool available for nucleic acid synthesis. mTORC1 had transcriptional effects on multiple enzymes contributing to purine synthesis, with expression of the mitochondrial tetrahydrofolate (mTHF) cycle enzyme methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) being closely associated with mTORC1 signaling in both normal and cancer cells. MTHFD2 expression and purine synthesis were stimulated by activating transcription factor 4 (ATF4), which was activated by mTORC1 independent of its canonical induction downstream of eukaryotic initiation factor 2α eIF2α phosphorylation. Thus, mTORC1 stimulates the mTHF cycle, which contributes one-carbon units to enhance production of purine nucleotides in response to growth signals.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26912861      PMCID: PMC4786372          DOI: 10.1126/science.aad0489

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

1.  Regulated translation initiation controls stress-induced gene expression in mammalian cells.

Authors:  H P Harding; I Novoa; Y Zhang; H Zeng; R Wek; M Schapira; D Ron
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

Review 2.  Serine, glycine and one-carbon units: cancer metabolism in full circle.

Authors:  Jason W Locasale
Journal:  Nat Rev Cancer       Date:  2013-07-04       Impact factor: 60.716

3.  Role of the transcription factor ATF4 in the anabolic actions of insulin and the anti-anabolic actions of glucocorticoids.

Authors:  Christopher M Adams
Journal:  J Biol Chem       Date:  2007-04-12       Impact factor: 5.157

4.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress.

Authors:  Heather P Harding; Yuhong Zhang; Huiquing Zeng; Isabel Novoa; Phoebe D Lu; Marcella Calfon; Navid Sadri; Chi Yun; Brian Popko; Richard Paules; David F Stojdl; John C Bell; Thore Hettmann; Jeffrey M Leiden; David Ron
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

5.  Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells.

Authors:  Christiaan F Labuschagne; Niels J F van den Broek; Gillian M Mackay; Karen H Vousden; Oliver D K Maddocks
Journal:  Cell Rep       Date:  2014-05-10       Impact factor: 9.423

Review 6.  Common corruption of the mTOR signaling network in human tumors.

Authors:  S Menon; B D Manning
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

7.  Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.

Authors:  Issam Ben-Sahra; Jessica J Howell; John M Asara; Brendan D Manning
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

8.  Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.

Authors:  Aaron M Robitaille; Stefan Christen; Mitsugu Shimobayashi; Marion Cornu; Luca L Fava; Suzette Moes; Cristina Prescianotto-Baschong; Uwe Sauer; Paul Jenoe; Michael N Hall
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

Review 9.  Signal integration by mTORC1 coordinates nutrient input with biosynthetic output.

Authors:  Christian C Dibble; Brendan D Manning
Journal:  Nat Cell Biol       Date:  2013-06       Impact factor: 28.824

10.  ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells.

Authors:  Qiuyan Wang; Helena Mora-Jensen; Marc A Weniger; Patricia Perez-Galan; Chris Wolford; Tsonwin Hai; David Ron; Weiping Chen; William Trenkle; Adrian Wiestner; Yihong Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-22       Impact factor: 11.205

View more
  282 in total

1.  Mapping Post-Translational Modifications of de Novo Purine Biosynthetic Enzymes: Implications for Pathway Regulation.

Authors:  Chunliang Liu; Giselle M Knudsen; Anthony M Pedley; Jingxuan He; Jared L Johnson; Tomer M Yaron; Lewis C Cantley; Stephen J Benkovic
Journal:  J Proteome Res       Date:  2019-04-18       Impact factor: 4.466

Review 2.  uORF-mediated translational control: recently elucidated mechanisms and implications in cancer.

Authors:  Hung-Hsi Chen; Woan-Yuh Tarn
Journal:  RNA Biol       Date:  2019-06-24       Impact factor: 4.652

Review 3.  Serine and one-carbon metabolism in cancer.

Authors:  Ming Yang; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 4.  Determinants of nutrient limitation in cancer.

Authors:  Mark R Sullivan; Matthew G Vander Heiden
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-06-04       Impact factor: 8.250

5.  Age modulates liver responses to asparaginase-induced amino acid stress in mice.

Authors:  Inna A Nikonorova; Qiaoqiao Zhu; Christina C Signore; Emily T Mirek; William O Jonsson; Bo Kong; Grace L Guo; William J Belden; Tracy G Anthony
Journal:  J Biol Chem       Date:  2019-08-14       Impact factor: 5.157

6.  Primary Metabolism co-Opted for Defensive Chemical Production in the Carabid Beetle, Harpalus pensylvanicus.

Authors:  Adam M Rork; Sihang Xu; Athula Attygalle; Tanya Renner
Journal:  J Chem Ecol       Date:  2021-03-10       Impact factor: 2.626

Review 7.  Spatial Organization of Metabolic Enzyme Complexes in Cells.

Authors:  Danielle L Schmitt; Songon An
Journal:  Biochemistry       Date:  2017-06-16       Impact factor: 3.162

Review 8.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

9.  Emerging role of mTOR in the response to cancer therapeutics.

Authors:  Erika Ilagan; Brendan D Manning
Journal:  Trends Cancer       Date:  2016-05

10.  Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth.

Authors:  Shauni Lien Geeraerts; Kim Rosalie Kampen; Karin Thevissen; Kim De Keersmaecker; Gianmarco Rinaldi; Purvi Gupta; Mélanie Planque; Nikolaos Louros; Elien Heylen; Kaat De Cremer; Katrijn De Brucker; Stijn Vereecke; Benno Verbelen; Pieter Vermeersch; Joost Schymkowitz; Frederic Rousseau; David Cassiman; Sarah-Maria Fendt; Arnout Voet; Bruno P A Cammue
Journal:  Mol Cancer Ther       Date:  2020-11-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.